SCHEMBL20205593

SCHEMBL20205593

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc4c(c1)oc1ccc5ccccc5c14)c1c2oc2ccccc21)C(C)(C)c1cc(-c2ccc4c(c2)oc2ccc5ccccc5c24)c2c(oc4ccccc42)c1-3

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ABCG2 Q9UNQ0 8/20 0.35
▸ PRKDC P78527 1/20 0.32
▸ PAX8 Q06710 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAPK3 P27361 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ HCRTR1 O43613 1/20 0.31
▸ ABCB1 P08183 1/20 0.31
▸ ABCC1 P33527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205579 0.96 TDP1 (0.34) TDP1L3MBTL1ABCG2PRKDCPAX8
SCHEMBL20205643 0.92 TDP1 (0.36) TDP1L3MBTL1ABCG2PRKDCPAX8
SCHEMBL20205638 0.92 TDP1 (0.37) TDP1L3MBTL1ABCG2PRKDCPAX8
SCHEMBL20205390 0.92 PRKDC (0.36) TDP1L3MBTL1ABCG2PRKDCCYP1A1
SCHEMBL20205725 0.91 ALOX5 (0.38) PRKDCNPC1RAB9AAHRPGR
SCHEMBL20205388 0.89 TDP1 (0.34) TDP1L3MBTL1ABCG2PRKDCCYP1A1
SCHEMBL20205601 0.89 PRKDC (0.34) PRKDCNPC1RAB9AAHRPGR
SCHEMBL20205399 0.89 ALOX5 (0.36) PRKDCNPC1RAB9ACYP1A2AHR
SCHEMBL20205580 0.88 TDP1 (0.33) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL20205524 0.88 GPR84 (0.35) TDP1L3MBTL1ABCG2PRKDCNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND TDP1 1461/4885L3MBTL1 1006/4885ABCG2 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback